Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | SNCA | P37840 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27365345 | 0.98 | LMNA (0.57) | LMNATDP1KMT2AL3MBTL1SNCA | |
| Charcoal, Activated SCHEMBL9762824 | 0.98 | LMNA (0.57) | LMNATDP1KMT2AL3MBTL1SNCA | |
| SCHEMBL21963615 | 0.89 | MAPT (0.63) | LMNAKMT2ASNCAALDH1A1KDM4E | |
| SCHEMBL21243068 | 0.87 | LMNA (0.62) | LMNATDP1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL1817895 | 0.81 | KMT2A (0.64) | LMNATDP1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL25009812 | 0.81 | L3MBTL1 (0.76) | LMNATDP1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL30556174 | 0.81 | L3MBTL1 (0.76) | LMNATDP1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL11524023 | 0.80 | L3MBTL1 (0.61) | LMNATDP1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL21946333 | 0.80 | KMT2A (0.51) | LMNATDP1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL9238807 | 0.80 | SNCA (0.77) | LMNAKMT2AL3MBTL1SNCAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 439 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114644613-A | Method for preparing artificial synthesized racemic nicotine | 湖北和诺生物工程股份有限公司 | 2022-06-21 | — | — | CN | claimed |
| WO-2021212880-A1 | METHOD FOR ASYMMETRICALLY PREPARING NICOTINE | 凯特立斯（深圳）科技有限公司 (CN) | 2021-10-28 | — | — | WO | claimed |
| EP-3362436-B1 | PROCESS FOR THE CATALYTIC DIRECTED CLEAVAGE OF AMIDE-CONTAINING COMPOUNDS | UNIV ANTWERPEN (BE) | 2021-06-30 | — | — | EP | claimed |
| EP-3362436-A1 | PROCESS FOR THE CATALYTIC DIRECTED CLEAVAGE OF AMIDE-CONTAINING COMPOUNDS | Universiteit Antwerpen (BE) | 2018-08-22 | — | — | EP | claimed |
| WO-2017046133-A1 | PROCESS FOR THE CATALYTIC DIRECTED CLEAVAGE OF AMIDE-CONTAINING COMPOUNDS | UNIVERSITEIT ANTWERPEN (BE) | 2017-03-23 | — | — | WO | claimed |
| EP-2947092-B1 | PROCESS FOR THE PREPARATION OF UNSATURATED TRIFLUOROMETHANESULPHONATE STEROID DERIVATIVES | OLON SPA (IT) | 2016-12-14 | — | — | EP | claimed |
| US-9315541-B2 | Process for the preparation of unsaturated trifluoromethanesulfonate steroid derivatives | OLON S.P.A. (IT) | 2016-04-19 | — | — | US | claimed |
| US-20150337007-A1 | PROCESS FOR THE PREPARATION OF UNSATURATED TRIFLUOROMETHANESULFONATE STEROID DERIVATIVES | OLON S.P.A. (IT) | 2015-11-26 | — | — | US | claimed |
| EP-2947092-A1 | PROCESS FOR THE PREPARATION OF UNSATURATED TRIFLUOROMETHANESULPHONATE STEROID DERIVATIVES | OLON S.p.A. (IT) | 2015-11-25 | — | — | EP | claimed |
| CN-103145704-A | 1,4-dihydro-1,8-nalidixic acid derivatives, their pharmaceutical composition and use of the pharmaceutical composition | JIANGSU SIMCERE PHARM CO LTD | 2013-06-12 | — | — | CN | claimed |
| US-20060147508-A1 | Concurrent Enhancement of Skin Penetration of Organic Base Active Agents and Organic Hydroxy Acid Active Agents as Their Ion-Pair Complexes | BIODERM RESEARCH (US) | 2006-07-06 | — | — | US | claimed |
| EP-0901377-A1 | ACNE TREATMENT | Mainstar One Investments Pty. Ltd. (AU) | 1999-03-17 | — | — | EP | claimed |
| EP-0576622-B1 | LITHOGRAPHIC PRINTING PLATES | EASTMAN KODAK CO (US) | 1997-11-05 | — | — | EP | claimed |
| WO-1997035597-A1 | ACNE TREATMENT | MAINSTAR ONE INVESTMENTS PTY. LTD. (AU) | 1997-10-02 | — | — | WO | claimed |
| US-5240945-A | Applying topically lower alkyl nicotinate | WARSHAW THELMA G (US) | 1993-08-31 | — | — | US | claimed |
| WO-1993015713-A2 | METHOD AND COMPOSITIONS FOR TREATING ACNE | WARSHAW THELMA G (US) | 1993-08-19 | — | — | WO | claimed |
| CN-1055925-A | Pyridine derivate and preparation method thereof | ICI PLC (GB) | 1991-11-06 | — | — | CN | claimed |
| US-5043162-A | Mixture of lower alkyl nicotinate and histamine hydrochloride | TRAGER SEYMOUR F (US) | 1991-08-27 | — | — | US | claimed |
| US-4543166-A | NICKEL, COBALT, ELECTRODEPOSITION, BRIGHTENERS, PUCTILITY, SULFONATES | OMI INTERNATIONAL CORPORATION (US) | 1985-09-24 | — | — | US | claimed |
| US-4204065-A | Soft quaternary surface active agents and method of using same | INTERX RESEARCH CORPORATION (US) | 1980-05-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150337007-A1 | PROCESS FOR THE PREPARATION OF UNSATURATED TRIFLUOROMETHANESULFONATE STEROID DERIVATIVES | NR5A1, AKR1C4, AR | LMNA 1680/4885TDP1 4077/4885KMT2A 2087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.